The Virginia Mason approach to localized pancreatic cancer

Surgical Oncology Clinics of North America

Volumn 13, Issue 4, 2004, Pages 663-674

  Picozzi, Vincent J ^a   Traverso, L William ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CAPECITABINE; CISPLATIN; DOCETAXEL; FLUOROURACIL; GEMCITABINE; OXALIPLATIN;

ANOREXIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; DEHYDRATION; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIARRHEA; ENDOSCOPY; ESOPHAGITIS; GASTRECTOMY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HISTOLOGY; HUMAN; HYPOVOLEMIA; LAPAROSCOPY; METASTASIS; MORBIDITY; MORTALITY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; PANCREAS CANCER; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; RADIATION SICKNESS; RADIOSENSITIZATION; REVIEW; SURGICAL TECHNIQUE; SURVIVAL TIME; TOXICITY; TUMOR BIOPSY;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PREOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WASHINGTON;

EID: 4444307877     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2004.06.002     Document Type: Review

References (28)

1. International Agency for Research on Cancer (IARC). Available at http://www.dep.iarc.fr/globocan.html.
2. A. Jemal, A. Thomas, T. Murray Cancer statistics 2002 CA Cancer J Clin 52 2002 23 47
3. J.E. Niederhuber, M.F. Brennan, and H.R. Menck The National Cancer Database report on pancreas cancer Cancer 76 1995 1671 1677
4. J.D. Birkmeyer, A.D. Siewers, S.R. Finlaysen, T.A. Stukel, F.L. Lucas, I. Batista Hospital volume and surgical mortality in the United States N Engl J Med 346 2002 1128 1137
5. Gastrointestinal Tumor Study Group Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreas cancer Cancer 59 1987 2006 2010
6. K.E. Bakkevold, B. Arnesjo, O. Dahl, and B. Kambestad Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - results of a controlled, prospective randomized multicenter study Eur J Cancer 29A 1993 698 703
7. J.H. Klinkenbijl, J. Jeekel, T. Sahmoud, R. van Pel, M.L. Couvreur, C.H. Veenhof Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cooperative group Ann Surg 230 1999 776 782
8. J.P. Neoptolemos, D.D. Stocken, H. Friess, C. Bassi, J.A. Dunn, H. Hickey A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1209
9. F.R. Spitz, J.L. Abbruzzese, J.E. Lee, P.W.T. Piskes, A.M. Lowy, C.J. Fenoglio Preoperative and postoperative chemoradiation in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol 15 1997 928 937
10. P. Freeney, L. Traverso, and J. Ryan Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography Am J Surg 165 1993 600 606
11. D.O. Faigel, G.G. Ginsberg, J.S. Bentz, T.K. Gupta, D.B. Smith, and M.L. Kochman Endoscopic ultrasound-guided real-time fine-needle aspiration biopsy of the pancreas in cancer patients with pancreatic lesions J Clin Oncol 15 1997 1439 1443
12. C. Raut, A. Grau, G. Staerkel, M. Kaw, E.P. Tamm, R.A. Wolff Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer J Gastrointest Surg 7 2003 118 128
13. M.F. Kalady, B.M. Clary, L.A. Clark, M. Gottfried, E.M. Rohren, R.E. Coleman Clinical utility of positive emission tomography in the diagnosis and management of periampullary neoplasms Ann Surg Oncol 9 2002 799 806
14. C.E. Forsmark, L. Lambiase, and S.B. Vogel Diagnosis of pancreatic cancer and prediction of unresectability using the tumor-associated antigen CA 19-9 Pancreas 9 1994 731 734
15. F. Tian, H.E. Appert, J. Myles, and J.M. Howard Prognostic value of serum CA 19.9 levels in pancreatic adenocarcinoma Ann Surg 215 1992 350 355
16. L.W. Traverso, H. Shiichi, and D. Low Useful benchmarks to evaluate outcomes after esophagectomy and pancreaticoduodenectomy Am J Surg 187 2004 604 608
17. T.A. Sohn, C.J. Yeo, J.L. Cameron, L. Koniaris, S. Kaushal, R.A. Abrams Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes and prognostic indicators J Gastrointest Surg 4 2000 567 579
18. J.P. Neoptolemos, J.A. Dunn, D.D. Stocken, J. Almond, K. Link, H. Beger Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized, controlled trial Lancet 358 2001 1576 1585
19. L.R. Holsti, K. Mattson, A. Niiraven, C.G. Standertskiold-Nordenstam, S. Stenman Enhancement of radiation effects by alpha-interferon in the treatment of small cell lung cancer Int J Radiat Oncol Biol Phys 13 1987 1161 1166
20. B. Sischy, R.L.S. Doggett, and J.M. Krall Definitive irradiation and chemotherapy for radiosensitization in the management of anal carcinoma. Interim report in Radiation Therapy Oncology Group No. 8314 J Natl Cancer Inst 81 1989 850 856
21. A. Ismail, C.J. Van Groeningen, A. Hardcastle, Q. Ren, G.W. Aherne, F. Geoffroy Modulation of fluorouracil cytotoxicity by interferon-alpha-2b and gamma Mol Pharm 53 1998 252 261
22. E.E. Vokes The promise of biochemical modulation in combined modality therapy Semin Oncol 21 S14 1994 29 33
23. S. Wadler, R. Wersto, V. Weinberg, D. Thompson, and E.L. Schwartz Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects Cancer Res Sep 15;50 18 1990 5735 5739
24. V.J. Picozzi, R.A. Kozarek, and L.W. Traverso Interferon-based adjuvant chemoradiation after'pancreaticoduodenectomy for pancreatic adenocarcinoma Am J Surg 185 2003 476 480
25. Y. Nukui, V.J. Picozzi, and L.W. Traverso Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy Am J Surg 179 2000 367 371
26. J.P. Hoffman, S. Lipsitz, T. Pisansky, J.L. Weese, L. Solin, and A.B. Benson III Phase II trial of preoperative radiation therapy and chemotherapy or patients with localized, resectable, adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study J Clin Oncol 16 1998 317 323
27. J.D. Wayne, E.D. Abdalla, R.A. Wolff Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation Oncologist 7 2002 34 45
28. A.D. Jacobs, H. Otero, V.J. Picozzi, D. Aboulafia, and P. Weiden Docetaxel and gemcitabine in metastatic pancreas cancer: results of a phase II trial Proc American Society of Clinical Oncology 19 2000 265